{"id":22,"date":"2013-02-05T09:31:46","date_gmt":"2013-02-05T14:31:46","guid":{"rendered":"https:\/\/sites.bu.edu\/phisspanish\/?page_id=22"},"modified":"2013-05-09T11:24:39","modified_gmt":"2013-05-09T15:24:39","slug":"publications","status":"publish","type":"page","link":"https:\/\/sites.bu.edu\/phisspanish\/research\/publications\/","title":{"rendered":"Publicaciones"},"content":{"rendered":"<div class=\"bu_collapsible_container \" aria-live=\"polite\" data-customize-animation=\"false\"><h3 class=\"bu_collapsible\" aria-expanded=\"false\"tabindex=\"0\" role=\"button\">2010-Presente<\/h3><div class=\"bu_collapsible_section\" style=\"display: none;\"><\/p>\n<ul>\n<li>Mitchell AA. Studies of drug-induced birth defects. In: Strom BL,  Kimmel  SE, Hennessy S, eds. Textbook of pharmacoepidemiology. 2nd ed  (in  press).<\/li>\n<\/ul>\n<ul>\n<li>Yau WP, Mitchell AA, Lin  KJ, Werler MM, Hern\u00e1ndez-D\u00edaz S. Use of   decongestants during pregnancy  and the risk of birth defects. Am J   Epidemiol 2013 (in press). PMCID:  PMC Journal \u2013 In Process.<\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1ndez-D\u00edaz S, Su YC, Mitchell AA, Kelley KE, Calafat AM, Hauser  R. Medications as a potential source of exposure to phthalates among  women of childbearing age. Reprod Toxicol 2013. doi:  10.1016\/j.reprotox.2013.01.001 (epub ahead of print). PMCID: PMC Journal  \u2013 In Process.<\/li>\n<\/ul>\n<ul>\n<li>Lin KJ, Mitchell AA, Yau WP, Louik C, Hern\u00e1ndez-D\u00edaz S. Safety of   macrolides during pregnancy. Am J Obstet Gynecol 2013. doi:  10.1016\/j.ajog.2012.12.023 (epub ahead of print). PMCID: PMC Journal \u2013  In Process.<\/li>\n<\/ul>\n<ul>\n<li>Van Marter LJ,  Hern\u00e1ndez-D\u00edaz S, Werler MM,  Louik C, Mitchell AA.   Nonsteroidal antiinflammatory drugs in late pregnancy and persistent   pulmonary hypertension of the newborn. Pediatrics 2013;131:79-87. doi:  10.1542\/peds.2012-0496. PMCID: PMC3529942.<\/li>\n<\/ul>\n<ul>\n<li>Louik C, Chambers C, Jacobs D, Rice F, Johnson D, Mitchell AA.  Influenza vaccine safety in pregnancy: can we identify exposures?.  Pharmacoepidemiol Drug Saf 2013;22:33-9. doi: 10.1002\/pds.3336.<\/li>\n<\/ul>\n<ul>\n<li>Radin RG, Mitchell AA, Werler MM. Predictors of recall certainty of  dates of analgesic medication use in pregnancy. Pharmacoepidemiol Drug  Saf 2013;22:25-32. doi: 10.1002\/pds.3300. PMCID: PMC3443548.<\/li>\n<\/ul>\n<ul>\n<li>Kelley KE, Chaplin EL, Mitchell AA. \u201cPhthalates\u201d: Kelley et al.  respond [letter to the editor]. Environ Health Perspect  2012;120(11):a416. doi: 10.1289\/ehp.1205763R.<\/li>\n<\/ul>\n<ul>\n<li>Ahrens K, Lash TL, Louik  C, Mitchell AA, Werler  MM. Correcting for  exposure misclassification  using survival analysis with a   time-varying exposure. Ann Epidemiol  2012;22:799-806. doi:   10.1016\/j.annepidem.2012.09.003. PMCID:  PMC3489973.<\/li>\n<\/ul>\n<ul>\n<li>Lin KJ, Mitchell AA, Yau  WP, Louik C,  Hern\u00e1ndez-D\u00edaz S. Maternal  exposure to amoxicillin and the  risk of oral clefts.  Epidemiology  2012;23(5):699-705. doi:   10.1097\/EDE.0b013e318258cb05. PMCID: PMC  Journal \u2013 In Process.<\/li>\n<\/ul>\n<ul>\n<li>Margulis AV, Mitchell AA, Gilboa SM,  Werler MM,  Mittleman MA,  Glynn RJ, Hern\u00e1ndez-D\u00edaz S, and the National  Birth Defects  Prevention  Study. Use of topiramate in pregnancy and risk  of oral clefts. Am J   Obstet Gynecol 2012;207(5):405.e1-7. doi:  10.1016\/j.ajog.2012.07.008.  PMCID:  PMC3484193.<\/li>\n<\/ul>\n<ul>\n<li>Yazdy MM, Tinker SC,  Mitchell AA, Demmer LA, Werler MM. Maternal  tea consumption during early  pregnancy and the risk of spina bifida.  Birth Defects Res A Clin Mol  Teratol 2012;94(10):756-61. doi:  10.1002\/bdra.23025.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Studies of  drug-induced birth defects. In: Strom BL,  Kimmel SE, Hennessy S, eds.  Pharmacoepidemiology. 5th ed. West Sussex,  UK: Wiley-Blackwell,  2012:487-504.<\/li>\n<\/ul>\n<ul>\n<li>Kelley KE, Hern\u00e1ndez-D\u00edaz  S, Chaplin EL, Hauser R, Mitchell AA.  Identification of phthalates in  medications and dietary supplement  formulations in the U.S. and Canada.  Environ Health Perspect  2012;120(3):379-84. doi:   10.1289\/ehp.1103998.\u00a0PMCID: PMC3295354.<\/li>\n<\/ul>\n<ul>\n<li>Collett BR, Cloonan YK,  Speltz ML, Anderka M, Werler MM.  Psychosocial functioning in children  with and without orofacial clefts  and their parents. Cleft Palate  Craniofac J 2012;49(4):397-405. doi:  10.1597\/10-007.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Fetal risk  from ACE inhibitors in the first  trimester&#8211;evidence is reassuring, but  risks remain from the  hypertension itself [editorial]. BMJ  2011;343:d6667. doi:  10.1136\/bmj.d6667.<\/li>\n<\/ul>\n<ul>\n<li>Yau WP, Lin KJ, Werler MM,  Louik C, Mitchell AA, Hern\u00e1ndez-D\u00edaz S.  Drug certainty-response in  interview-based studies. Pharmacoepidemiol  Drug Saf 2011;20:1210-6. doi:  10.1002\/pds.2234. PMCID: PMC3222943.<\/li>\n<\/ul>\n<ul>\n<li>Gilboa S, Broussard C,  Devine O, Duwe K, Flak A, Boulet S, Moore C,  Werler MM, Honein M.  Influencing clinical practice regarding the use  of antiepileptic  medications during pregnancy: modeling the potential  impact on the  prevalences of spina bifida and cleft palate in the  United States. Am J  Med Genet C Semin Med Genet 2011;157:234-46. doi:  10.1002\/ajmg.c.30306.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Louik C,  Mitchell AA. Case-control  studies for  identifying novel teratogens. Am J  Med Genet C Semin Med Genet   2011;157:201-8. doi: 10.1002\/ajmg.c.30307.  PMCID: PMC3483035.<\/li>\n<\/ul>\n<ul>\n<li>Ahrens K, Yazdy M,  Mitchell AA, Werler MM. Folic acid intake and  spina bifida in the era of  dietary folic acid fortification.  Epidemiology 2011;22(5):731-7. doi:  10.1097\/EDE.0b013e3182227887.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Adverse drug  reactions in utero: perspectives on  teratogens and strategies for the  future [editorial]. Clin Pharmacol  Ther 2011;89:781-3. doi:  10.1038\/clpt.2011.52.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA, Gilboa SM,  Werler MM, Kelley KE, Louik C,  Hern\u00e1ndez-D\u00edaz S, and the National Birth  Defects Prevention Study.  Medication use during pregnancy, with  particular focus on prescription  drugs: 1976-2008. Am J Obstet Gynecol  2011;205:51.e1-8. doi:  10.1016\/j.ajog.2011.02.029. PMCID: PMC Journal \u2013  In Process.<\/li>\n<\/ul>\n<ul>\n<li>Yazdy MM, Mitchell AA, Liu  S, Werler MM. Maternal dietary glycaemic  intake during pregnancy and  the risk of birth defects. Paediatr  Perinat Epidemiol 2011;25:340-6.  doi:10.1111\/j.1365-3016.2011.01198.x.  PMCID: PMC3474333.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM. Birth defects.  In: Buck-Louis GM, Platt RW, eds.  Reproductive and perinatal  epidemiology. New York: Oxford University  Press, 2011:186-203.<\/li>\n<\/ul>\n<ul>\n<li>Schatz M, Chambers CD,  Jones KL, Louik C, Mitchell AA. The safety  of influenza immunizations  and treatment during pregnancy: the Vaccines  and Medications in  Pregnancy Surveillance System. Am J Obstet Gynecol  2011;204(6 Suppl.  1):S64-8. doi: 10.1016\/j.ajog.2011.01.047.<\/li>\n<\/ul>\n<ul>\n<li>Dufton L, Speltz ML, Kelly  JP, Leroux B, Collett BR, Werler MM.  Psychosocial outcomes in children  with hemifacial microsomia. J Pediatr  Psychol 2011;36(7):794-805. doi:  10.1093\/jpepsy\/jsq112. PMCID:  PMC3146752.<\/li>\n<\/ul>\n<ul>\n<li>Collett BR, Speltz ML,  Cloonan YK, Leroux BG, Kelly JP, Werler MM.  Neurodevelopmental outcomes  in children with hemifacial microsomia.  Arch Pediatr Adolesc Med  2011;165(2):134-40. PMCID: PMC3142696.<\/li>\n<\/ul>\n<p><\/div>\n<\/div>\n\n<div class=\"bu_collapsible_container \" aria-live=\"polite\" data-customize-animation=\"false\"><h3 class=\"bu_collapsible\" aria-expanded=\"false\"tabindex=\"0\" role=\"button\">2000-2010<\/h3><div class=\"bu_collapsible_section\" style=\"display: none;\"><\/p>\n<ul>\n<li>Toh S, Mitchell AA,  Anderka M, de Jong-van den Berg LTW,  Hern\u00e1ndez-D\u00edaz S, and the National  Birth Defects Prevention Study.  Antibiotics and oral contraceptive  failure: a case-crossover study.  Contraception 2010;83(5):418-25. doi:   10.1016\/j.contraception.2010.08.020.<\/li>\n<\/ul>\n<ul>\n<li>Hernandez  RK, Mitchell AA, Werler MM. Decongestant use during  pregnancy and its  association with preterm delivery. Birth Defects Res A  Clin Mol Teratol  2010;88:715-21.<\/li>\n<\/ul>\n<ul>\n<li>Louik  C, Schatz M, Hern\u00e1ndez-D\u00edaz S, Werler MM, Mitchell AA. Asthma  in  pregnancy and its pharmacologic treatment. Ann Allergy Asthma  Immunol  2010;105:110-7. PMCID: PMC2953247.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Proton-pump  inhibitors and birth defects&#8211;some  reassurance, but more needed  [editorial]. N Engl J Med  2010;363(22):2161-3.<em><em><em> <\/em><\/em><\/em><\/li>\n<\/ul>\n<ul>\n<li>Louik  C, Gardiner P, Kelley K, Mitchell AA. Use of herbal  treatments in  pregnancy. Am J Obstet Gynecol 2010;202(5):439.e1-10.  PMCID: PMC2867842.<em><em><em> <\/em><\/em><\/em><\/li>\n<\/ul>\n<ul>\n<li>Burris  HH, Mitchell AA, Werler MM. Periconceptional multivitamin  use and its  association with infant birth weight disparities. Ann  Epidemiol  2010;20:233-40. doi: 10.1016\/j.annepidem.2009.12.003.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM. Hypothesis: could Epstein-Barr virus play a role in the  development of gastroschisis? Birth Defects Res A Clin Mol Teratol  2010;88(2):71-5. doi: 10.1002\/bdra.20640.<\/li>\n<\/ul>\n<ul>\n<li>Yazdy  MM, Liu S, Mitchell AA, Werler MM. Maternal dietary glycemic  intake and  the risk of neural tube defects. Am J Epidemiol  2010;171(4):407-14.  doi: 10.1093\/aje\/kwp395. PMCID: PMC2842193.<\/li>\n<\/ul>\n<ul>\n<li>Hobbs CA, Shaw GM, Werler MM, Mosley B. Folate status and birth  defect risk: epidemiological perspective. In: Bailey LB, ed. Folate in  health and disease. 2nd ed. Boca Raton, FL: CRC Press, 2009:133-54.<\/li>\n<\/ul>\n<ul>\n<li>Toh S, Mitchell AA, Louik  C, Werler MM Chambers CD, Hern\u00e1ndez-D\u00edaz  S. Antidepressant use during  pregnancy and the risk of preterm delivery  and fetal growth restriction.  J Clin Psychopharmacol  2009;29(6):555-60. doi:  10.1097\/JCP.0b013e3181bf344c. PMCID:  PMC3206605.<\/li>\n<\/ul>\n<ul>\n<li>Cloonan YK, Kifle Y, Davis S, Speltz ML, Werler MM, Starr JR. Sleep  outcomes in children with hemifacial microsomia and controls: a  follow-up study. Pediatrics 2009;124(2):e313-21. doi:  10.1542\/peds.2008-3488. PMCID: PMC2739665.<\/li>\n<\/ul>\n<ul>\n<li>Li L, Werler MM. Fruit and  vegetable intake and risk of upper  respiratory tract infection in  pregnant women. Public Health Nutr  2009;13(2):276-82. doi:  10.1017\/S1368980009990590. PMCID: PMC2808435.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Starr JR, Cloonan YK, Speltz ML. Hemifacial microsomia:  from gestation to childhood. J Craniofac Surg 2009;20(Suppl. 1):664-9.  PMCID: PMC2791372.<\/li>\n<\/ul>\n<ul>\n<li>Toh S, Mitchell AA, Louik  C, Werler MM, Chambers CD, Hern\u00e1ndez-D\u00edaz  S. Selective serotonin  reuptake inhibitor use and risk of gestational  hypertension. Am J  Psychiatry 2009;166:320-8. doi:  10.1176\/appi.ajp.2008.08060817. PMCID:  PMC2735348.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Prescription medication  sharing [letter to the  editor]. Am J Public Health 2008;98(11):1926-7.  doi:  10.2105\/AJPH.2008.144261.<\/li>\n<\/ul>\n<ul>\n<li>Petersen EE,  Mitchell AA, Carey JC, Werler MM, Louik C, Rasmussen  SA, and the  National Birth Defects Prevention Study. Maternal exposure  to statins  and risk for birth defects: a case-series approach [research  letter]. Am  J Med Genet A 2008;146A(20):2701-5. doi:  10.1002\/ajmg.a.32493.<\/li>\n<\/ul>\n<ul>\n<li>Nelson JW, Werler MM. Socioeconomic status as a modifier of the  relationship between antibiotic use during pregnancy and birthweight.  Birth 2008;35(3):196-203. doi: 10.1111\/j.1523-536X.2008.00240.x.<\/li>\n<\/ul>\n<ul>\n<li>Toh  S, Mitchell AA, Werler MM, Hern\u00e1ndez-D\u00edaz S. Toh et al. respond  to  &#8220;Compromise or compromising?&#8221; [commentary]. Am J Epidemiol   2008;167(6):644-5. doi: 10.1093\/aje\/kwm369.<\/li>\n<\/ul>\n<ul>\n<li>Toh  S, Mitchell AA, Werler MM, Hern\u00e1ndez-D\u00edaz S. Sensitivity and  specificity  of computerized algorithms to classify gestational periods  in the  absence of information on date of conception. Am J Epidemiol   2008;167(6):633-40. doi: 10.1093\/aje\/kwm367.<\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1ndez-D\u00edaz  S, Van Marter LJ, Werler MM, Louik C, Mitchell AA.   Risk factors for  persistent pulmonary hypertension of the newborn.   Pediatrics  2007;120(2);272-82.<\/li>\n<\/ul>\n<ul>\n<li>Louik  C, Lin AE, Werler MM, Hern\u00e1ndez-D\u00edaz S, Mitchell AA.  First-trimester  use of selective serotonin-reuptake inhibitors and the  risk of birth  defects. N Engl J Med 2007;356:2675-83.<\/li>\n<\/ul>\n<ul>\n<li>Leeder  JS, Mitchell AA.  Application of pharmacogenomic strategies  to the  study of drug-induced birth defects.  Clin Pharmacol Ther   2007;81(4):595-9.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM. Maternal smoking and undescended testes: reaching a tipping point [commentary]. Epidemiology 2007;18:197-8.<\/li>\n<\/ul>\n<ul>\n<li>Badovinac RL, Werler MM,  Williams PL, Kelsey KT, Hayes C. Folic  acid-containing supplement  consumption during pregnancy and risk for  oral clefts: a meta-analysis.  Birth Defects Res A Clin Mol Teratol  2007;79:8-15.<em><br \/>\n<\/em><\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1ndez-D\u00edaz  S, Schisterman EF, Hern\u00e1n MA. Hern\u00e1ndez-D\u00edaz et al.  respond to &#8220;The  perils of birth weight&#8221; [commentary]. Am J Epidemiol  2006;164:1124-5.<\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1ndez-D\u00edaz S, Schisterman EF, Hern\u00e1n MA.  The birth weight &#8220;paradox&#8221; uncovered?  Am J Epidemiol 2006;164:1115-20.<\/li>\n<\/ul>\n<ul>\n<li>Meijer  WM, Werler MM, Louik C, Hern\u00e1ndez-D\u00edaz S, de Jong-van den  Berg LTW,  Mitchell AA.  Can folic acid protect against congenital heart  defects in  Down syndrome?  Birth Defects Res A Clin Mol Teratol  2006;76(10):714-7.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM.  Teratogen update: pseudoephedrine.  Birth Defects Res A Clin Mol Teratol 2006;76(6):445-52.<\/li>\n<\/ul>\n<ul>\n<li>Louik  C, Hern\u00e1ndez-D\u00edaz S, Werler MM, Mitchell AA. Nausea and  vomiting in  pregnancy: maternal characteristics and risk factors.  Paediatr Perinat  Epidemiol 2006;20:270-8.<\/li>\n<\/ul>\n<ul>\n<li>Chambers  CD, Hern\u00e1ndez-D\u00edaz S, Van Marter LJ, Werler MM, Louik C,  Jones KL,  Mitchell AA.  Selective serotonin-reuptake inhibitors and  risk of  persistent pulmonary hypertension of the newborn.  N Engl J Med   2006;354(6):579-87.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Prone to sleep, prone to pyloric stenosis? [commentary]. Epidemiology 2006;17:136-7.<em> <\/em><\/li>\n<\/ul>\n<ul>\n<li>Werler  MM, Mitchell AA, Hern\u00e1ndez-D\u00edaz S, Honein MA, and the  National Birth  Defects Prevention Study. Use of over-the-counter  medications during  pregnancy. Am J Obstet Gynecol 2005;193:771-7.<\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1ndez-D\u00edaz  S, Wu XF, Hayes C, Werler MW, Ashok TDS, Badovinac  R, Kelsey KT,  Mitchell AA. Methylenetetrahydrofolate reductase  polymorphisms and the  risk of gestational hypertension. Epidemiology  2005;16(5):628-34.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Studies of drug-induced birth defects. In: Strom BL,  ed.  Pharmacoepidemiology. 4th ed. New York: Wiley, 2005:501-15.<\/li>\n<\/ul>\n<ul>\n<li>Louik C, Mitchell AA. Post-marketing surveillance using  pharmacy-based  cohorts: results of a pilot study. Pharmacoepidemiol  Drug Saf  2005;14:289-95.<\/li>\n<\/ul>\n<ul>\n<li>de  Jong-van den Berg LTW, Hern\u00e1ndez-D\u00edaz S, Werler MM, Louik C,  Mitchell  AA. Trends and predictors of folic acid awareness and  periconceptional  use in pregnant women. Am J Obstet Gynecol  2005;192:121-8.<\/li>\n<\/ul>\n<ul>\n<li>Werler  MM, Sheehan JE, Mitchell AA. Gulf war veterans and  hemifacial  microsomia. Birth Defects Res A Clin Mol Teratol  2005;73:50-2.<\/li>\n<\/ul>\n<ul>\n<li>Chan KA, Hern\u00e1ndez-D\u00edaz S. Pharmacoepidemiology and rheumatic disorders. Rheum Dis Clin North Am 2004;30(4):835-50.<\/li>\n<\/ul>\n<ul>\n<li>Meyer K, Williams P, Hern\u00e1ndez-D\u00edaz S, Cnattingius S. Smoking and  the  risk of oral clefts: exploring the impact of study designs.  Epidemiology  2004;15(6):671-8.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Sheehan JE, Hayes C, Padwa BL, Mitchell AA, Mulliken JB.   Demographic and reproductive factors associated with hemifacial   microsomia. Cleft Palate Craniofac J 2004;41:494-500.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Sheehan JE, Hayes C, Mitchell AA, Mulliken JB. Vasoactive   exposures, vascular events, and hemifacial microsomia. Birth Defects  Res  A Clin Mol Teratol 2004;70(6):389-95.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Systematic identification of drugs that cause birth   defects&#8211;a new opportunity [editorial]. N Engl J Med 2003;349:2556-9.<\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1ndez-D\u00edaz S, de Abajo FJ. Psychomotor development in children  and  antenatal psychotropic and anti-epileptic drugs [commentary]. Eur J   Epidemiol 2003;18(8):743-4.<\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1ndez-D\u00edaz S, Hern\u00e1n MA, Meyer K, Werler MM, Mitchell AA.   Case-crossover and case-time-control designs in birth defects   epidemiology. Am J Epidemiol 2003;158:385-91.<\/li>\n<\/ul>\n<ul>\n<li>Meyer KA, Werler MM, Hayes C, Mitchell AA. Low maternal alcohol   consumption during pregnancy and oral clefts in offspring: the Slone   Birth Defects Study. Birth Defects Res A Clin Mol Teratol   2003;67:509-14.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Sheehan JE, Mitchell AA. Association of vasoconstrictive   exposures with risks of gastroschisis and small intestinal atresia.   Epidemiology 2003;14:349-54.<\/li>\n<\/ul>\n<ul>\n<li>Louik C, Mitchell AA. Prenatal prescription of macrolide antibiotics  and  infantile hypertrophic pyloric stenosis [letter to the editor].  Obstet  Gynecol 2003;101(4):816.<\/li>\n<\/ul>\n<ul>\n<li>Waller DK, Tita ATN, Werler MM, Mitchell AA. Association between   pre-pregnancy maternal body mass index and the risk of having an infant   with a congenital diaphragmatic hernia. Birth Defects Res A Clin Mol   Teratol 2003;67:73-6.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Louik C, Mitchell AA. Epidemiologic analysis of maternal   factors and amniotic band defects. Birth Defects Res A Clin Mol Teratol   2003;67:68-72.<\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1ndez-D\u00edaz S, Werler MM, Louik C, Mitchell AA. Risk of  gestational  hypertension in relation to folic acid supplementation  during pregnancy.  Am J Epidemiol 2002;156:806-12.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM.  Exposure assessment in studies of oral clefts.  In:   Wyszynski DF, ed.  Cleft lip and palate: from origin to treatment.  New   York: Oxford University Press, 2002:108-16.<\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1ndez-D\u00edaz S. Iatrogenic legacy from diethylstilbestrol exposure [commentary]. Lancet 2002;359:1081-2.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Infertility treatment&#8211;more risks and challenges [editorial]. N Engl J Med 2002;346:769-70.<\/li>\n<\/ul>\n<ul>\n<li>Louik C, Werler MM, Mitchell AA. Erythromycin use during pregnancy  in  relation to pyloric stenosis. Am J Obstet Gynecol 2002;186:288-90.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Sheehan JE, Mitchell AA. Maternal medication use and  risks of  gastroschisis and small intestinal atresia. Am J Epidemiol   2002;155:26-31.<\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1n MA, Hern\u00e1ndez-D\u00edaz S, Werler MM, Mitchell AA. Causal  knowledge as  a prerequisite for confounding evaluation: an application  to birth  defects epidemiology. Am J Epidemiol 2002;155:176-84.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM. Additional insights into the etiology of cardiac anomalies [editorial]. Epidemiology 2001;12:482-4.<\/li>\n<\/ul>\n<ul>\n<li>Kaufman DW, Rosenberg L, Mitchell AA. Signal generation and   clarification: use of case-control data. Pharmacoepidemiol Drug Saf   2001;10:197-203.<\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1ndez-D\u00edaz S, Werler MM, Walker AM, Mitchell AA. Neural tube  defects  in relation to use of folic acid antagonists during pregnancy.  Am J  Epidemiol 2001;153:961-8.<\/li>\n<\/ul>\n<ul>\n<li>Hern\u00e1ndez-D\u00edaz S, Werler MM, Walker AM, Mitchell AA. Folic acid   antagonists during pregnancy and the risk of birth defects. N Engl J Med   2000;343:1608-14.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Special considerations in studies of drug-induced birth   defects. In: Strom BL, ed. Pharmacoepidemiology. 3rd ed. Chichester,  UK:  John Wiley and Sons, 2000:749-63.<\/li>\n<\/ul>\n<ul>\n<li>Louik C, Frumkin H, Ellenbecker MJ, Goldman RH, Werler MM, Mitchell  AA.  Use of a job-exposure matrix to assess occupational exposures in   relation to birth defects. J Occup Environ Med 2000;42:693-703.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Mitchell AA. Folic acid and neural tube defect risk [letter to the editor]. N Engl J Med 2000;342:1135-6.<\/li>\n<\/ul>\n<p><\/div>\n<\/div>\n\n<div class=\"bu_collapsible_container \" aria-live=\"polite\" data-customize-animation=\"false\"><h3 class=\"bu_collapsible\" aria-expanded=\"false\"tabindex=\"0\" role=\"button\">1990-2000<\/h3><div class=\"bu_collapsible_section\" style=\"display: none;\"><\/p>\n<ul>\n<li>Werler MM, Louik C, Mitchell AA. Achieving a public health   recommendation for preventing neural tube defects with folic acid. Am J   Public Health 1999;89:1637-40.<\/li>\n<\/ul>\n<ul>\n<li>Lieff S, Olshan AF, Werler M, Strauss RP, Smith J, Mitchell A.  Maternal  cigarette smoking during pregnancy and risk of oral clefts in  newborns.  Am J Epidemiol 1999;150:683-94.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Hayes C, Louik C, Shapiro S, Mitchell AA. Multivitamin   supplementation and risk of birth defects. Am J Epidemiol   1999;150:675-82.<\/li>\n<\/ul>\n<ul>\n<li>Lieff S, Olshan AF, Werler M, Savitz DA, Mitchell AA. Selection bias  and  the use of controls with malformations in case-control studies of  birth  defects. Epidemiology 1999;10:238-41.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Intracytoplasmic sperm injection: offering hope for a  term  pregnancy and a healthy child? [editorial]. BMJ 1997;315:1245-6.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM. Teratogen update: smoking and reproductive outcomes. Teratology 1997;55:382-8.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Cragan JD, Wasserman CR, Shaw GM, Erickson JD, Mitchell  AA.  Multivitamin supplementation and multiple births. Am J Med Genet   1997;71:93-6.<\/li>\n<\/ul>\n<ul>\n<li>Hayes C, Werler MM, Willett WC, Mitchell AA. Case-control study of   periconceptional folic acid supplementation and oral clefts. Am J   Epidemiol 1996;143:1229-34.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Louik C, Shapiro SS, Mitchell AA. Prepregnant weight in   relation to risk of neural tube defects. J Am Med Assoc   1996;275:1089-92.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Mitchell AA. More on folic acid and neural tube defects [letter to the editor]. Am J Public Health 1995;85:269.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA, Werler MM, Shapiro S. Response to the commentary  &#8220;Should we  consider a subject&#8217;s knowledge of the etiologic hypothesis  in the  analysis of case-control studies?&#8221; [commentary]. Am J Epidemiol   1995;141:297-8.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA.  Special considerations in studies of drug-induced  birth  defects.  In: Strom BL, ed.  Pharmacoepidemiology.  2nd ed.   Chichester,  UK: John Wiley and Sons, 1994:595-608.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Louik C, Shapiro S, Mitchell AA.  Ovulation induction and risk of neural tube defects.  Lancet 1994;344:445-6.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Mitchell AA. Case-control study of vitamin  supplementation  and neural tube defects: consideration of potential  confounding by  lifestyle factors. Ann N Y Acad Sci 1993;678:276-83.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid  exposure  and risk of occurrent neural tube defects. J Am Med Assoc   1993;269:1257-61.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA, Werler MM, Shapiro S. Analyses and reanalyses of   epidemiologic data: learning lessons and maintaining perspective   [commentary]. Teratology 1992;46:209-11.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Mitchell AA, Shapiro S.  First trimester maternal  medication  use in relation to gastroschisis.  Teratology 1992;45:361-7.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Mitchell AA, Shapiro S.  Demographic, reproductive,  medical,  and environmental factors in relation to gastroschisis.   Teratology  1992;45:353-60.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA.  Oral retinoids: what should the prescriber know about   their teratogenic hazards among women of child-bearing potential?  Drug   Saf 1992;7:79-85.<em> <\/em><\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Lammer EJ, Rosenberg L, Mitchell AA.  Maternal alcohol  use in  relation to selected birth defects.  Am J Epidemiol  1991;134:691-8.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell  AA.  Teratogens and the dermatologist: new knowledge,  responsibilities,  and opportunities [editorial].  Arch Dermatol  1991;127:399-401.<\/li>\n<\/ul>\n<p><\/div>\n<\/div>\n\n<div class=\"bu_collapsible_container \" aria-live=\"polite\" data-customize-animation=\"false\"><h3 class=\"bu_collapsible\" aria-expanded=\"false\"tabindex=\"0\" role=\"button\">1980-1990<\/h3><div class=\"bu_collapsible_section\" style=\"display: none;\"><\/p>\n<ul>\n<li>Werler MM, Lammer EJ,  Rosenberg L, Mitchell AA.  Maternal vitamin A  supplementation in  relation to selected birth defects.  Teratology  1990;42:497-503.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Lammer EJ,  Rosenberg L, Mitchell AA.  Maternal cigarette  smoking during pregnancy  in relation to oral clefts.  Am J Epidemiol  1990;132:926-32.<\/li>\n<\/ul>\n<ul>\n<li>Werler MM, Mitchell AA,  Shapiro S.  The relation of aspirin use  during the first trimester of  pregnancy to congenital cardiac defects.   N Engl J Med 1989;321:1639-42.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA. Slone Epidemiology Unit Birth Defects Study. Genetic Resour 1988;4:31-2.<\/li>\n<\/ul>\n<ul>\n<li>Louik C, Mitchell A,  Werler M, Hanson J, Shapiro S.  Maternal  exposure to spermicides in  relation to certain birth defects.  N Engl J  Med 1987;317:474-8.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA, Cottler LB,  Shapiro S.  Effect of questionnaire design  on recall of drug exposure  in pregnancy.  Am J Epidemiol  1986;123:670-6.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA, Schwingl  PJ, Rosenberg L, Louik C, Shapiro S. Birth  defects in relation to  Bendectin use in pregnancy: pyloric stenosis. Am  J Obstet Gynecol  1983;147:737-42.<\/li>\n<\/ul>\n<ul>\n<li>Rosenberg L, Mitchell  AA, Parsells J, Pashayan H, Louik C, Shapiro  S.  Lack of relation of  oral clefts to diazepam use during pregnancy.  N  Engl J Med  1983;309:1282-5.<\/li>\n<\/ul>\n<ul>\n<li>Shapiro S, Slone D,  Heinonen OP, Kaufman DW, Rosenberg L, Mitchell  AA, Helmrich SP. Birth  defects and vaginal spermicides. J Am Med Assoc  1982;247:2381-4.<\/li>\n<\/ul>\n<ul>\n<li>Rosenberg L, Mitchell  AA, Shapiro S, Slone D. Selected birth  defects in relation to  caffeine-containing beverages. J Am Med Assoc  1982;247:1429-32.<\/li>\n<\/ul>\n<ul>\n<li>Mitchell AA, Rosenberg  L, Shapiro S, Slone D. Birth defects related  to Bendectin use in  pregnancy: oral clefts and cardiac defects. J Am  Med Assoc  1981;245:2311-4.<\/li>\n<\/ul>\n<ul>\n<li>Slone D, Shapiro S,  Mitchell AA.  Strategies for studying the  effects of the antenatal  chemical environment on the fetus.  In:  Schwarz RH, Yaffe SJ, eds.  Drug  and chemical risks to the fetus and  newborn.  New York: Alan R. Liss,  Inc., 1980.<\/li>\n<\/ul>\n<p><\/div>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4351,"featured_media":0,"parent":11,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/sites.bu.edu\/phisspanish\/wp-json\/wp\/v2\/pages\/22"}],"collection":[{"href":"https:\/\/sites.bu.edu\/phisspanish\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.bu.edu\/phisspanish\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/phisspanish\/wp-json\/wp\/v2\/users\/4351"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/phisspanish\/wp-json\/wp\/v2\/comments?post=22"}],"version-history":[{"count":20,"href":"https:\/\/sites.bu.edu\/phisspanish\/wp-json\/wp\/v2\/pages\/22\/revisions"}],"predecessor-version":[{"id":135,"href":"https:\/\/sites.bu.edu\/phisspanish\/wp-json\/wp\/v2\/pages\/22\/revisions\/135"}],"up":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/phisspanish\/wp-json\/wp\/v2\/pages\/11"}],"wp:attachment":[{"href":"https:\/\/sites.bu.edu\/phisspanish\/wp-json\/wp\/v2\/media?parent=22"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}